Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Cigna : CEO Received $21.9 Million in 2016

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/18/2017 | 04:48am CET

March 18--Cigna Corp. CEO David Cordani's compensation totaled $21.9 million in 2016, less than half what he received in 2015.

The value of restricted stock awards that vested during the year made up 88 percent of his package.

The Courant calculates compensation as the sum of salary, bonuses, value gained on the exercise of stock options and the vesting of stock awards, and the value of perquisites, such as the 401(k) match and use of corporate aircraft.

As a result of Obamacare, Cigna is not allowed to deduct the salaries, bonuses, stock awards and option awards it grants employees of any amount past $500,000. A proposal to repeal and replace the law would restore the tax deductibility of bonuses and stock grants and up to $1 million in salary.

Cigna-HealthSpring Herb Fritch, who retired in early November, earned $16.9 million during the year, with $8.8 million of his compensation coming from accelerated vesting of stock options when he retired.

The proxy statement, filed after the close of the stock market on Friday, also suggested that shareholders authorize the issuing of more stock options and restricted stock, because the pool of potential awards could run out in 2018. The company's six highest paid officers have received 23 percent of all the stock options issued since April 2013.

Separately, Cordani was awarded restricted stock currently worth $6.7 million and stock options currently valued at $6 million. These awards could be worth more or less in the future, depending on how the stock's price performs.

___

(c)2017 The Hartford Courant (Hartford, Conn.)

Visit The Hartford Courant (Hartford, Conn.) at www.courant.com

Distributed by Tribune Content Agency, LLC.

© Tribune Content Agency, source Regional News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
03/18 CIGNA : CEO Received $21.9 Million in 2016
03/17 U.S. investigates four insurers over Medicare payments
03/14 CIGNA : Sponsors U.N. Discussion on Women and Non-Communicable Diseases
03/09 CIGNA : Foundation Announces Grants Available in U.S. Virgin Islands
03/08 Industry questions higher insurance costs under Republican plan
03/08 CIGNA CORPORATION : ex-dividend day
03/07 CIGNA : Receives Excellence Award for Using Outcomes-based Contracting as a Stra..
03/03 CIGNA : Novant Health Continues to Improve Quality and Lower Costs Through Cigna..
03/02 DAVITA : Cigna and HealthCare Partners Form Alliance to Deliver Innovative Healt..
03/01 CIGNA FOUNDATION : Announces Grants Available in U.S. Virgin Islands
More news
Sector news : Managed Healthcare - NEC
03/17 U.S. investigates four insurers over Medicare payments
03/08 Industry questions higher insurance costs under Republican plan
03/08DJHealth Costs Get a Rethink -- WSJ
03/07 Drugmaker shares slip as Trump tweets about pricing system
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
03/20 Republicans tweaking healthcare bill, adding tax credits for older Americans ..
03/15 If Apple's Serious About The Car, It Should Buy GM (And A Health Insurance Co..
03/14 Healthcare stocks under water as GOP tries to advance ACA replacement
03/14 CBO analyzes GOP healthcare plan
03/07 Investors voting early on potential winners/losers under Trump's healthcare p..
Advertisement
Financials ($)
Sales 2017 40 445 M
EBIT 2017 3 393 M
Net income 2017 2 345 M
Finance 2017 98,0 M
Yield 2017 0,02%
P/E ratio 2017 16,43
P/E ratio 2018 14,24
EV / Sales 2017 0,95x
EV / Sales 2018 0,89x
Capitalization 38 400 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 164 $
Spread / Average Target 9,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION12.16%38 400
UNITEDHEALTH GROUP INC4.79%159 510
AETNA INC4.10%45 401
ANTHEM INC16.15%44 149
HUMANA INC4.67%30 812
CENTENE CORP18.42%11 523
More Results